Characterization_NN
of_IN
the_DT
nuclear_JJ
and_CC
cytoplasmic_JJ
components_NNS
of_IN
the_DT
lymphoid-specific_JJ
nuclear_JJ
factor_NN
of_IN
activated_VBN
T_NN
cells_NNS
-LRB-_-LRB-
NF-AT_NN
-RRB-_-RRB-
complex_NN
._.

The_DT
lymphoid-specific_JJ
transcription_NN
complex_NN
,_,
NF-AT_NN
,_,
is_VBZ
involved_VBN
in_IN
early_JJ
gene_NN
activation_NN
in_IN
T_NN
cells_NNS
and_CC
is_VBZ
assembled_VBN
from_IN
a_DT
pre-existing_JJ
,_,
T_NN
cell_NN
restricted_JJ
cytoplasmic_JJ
factor_NN
and_CC
an_DT
inducible_JJ
ubiquitous_JJ
nuclear_JJ
component_NN
within_IN
30_CD
min_NN
after_IN
activation_NN
through_IN
the_DT
antigen_NN
receptor_NN
._.

Recent_JJ
studies_NNS
have_VBP
implicated_VBN
the_DT
family_NN
of_IN
AP1_NN
factors_NNS
as_IN
components_NNS
of_IN
the_DT
murine_JJ
NF-AT_NN
complex_NN
._.

Evidence_NN
is_VBZ
provided_VBN
here_RB
that_IN
the_DT
nuclear_JJ
component_NN
of_IN
human_JJ
NF-AT_NN
contains_VBZ
the_DT
phorbol_NN
ester-inducible_JJ
transcription_NN
factor_NN
AP1_NN
-LRB-_-LRB-
Jun\/Fos_NN
-RRB-_-RRB-
._.

We_PRP
further_RB
characterize_VBP
which_WDT
AP1_NN
family_NN
members_NNS
can_MD
assume_VB
this_DT
role_NN
._.

Antisera_NN
to_TO
Fos_NN
inhibits_VBZ
NF-AT_NN
DNA_NN
binding_NN
as_IN
does_VBZ
an_DT
oligonucleotide_NN
containing_VBG
a_DT
binding_NN
site_NN
for_IN
AP1_NN
._.

Constitutive_JJ
expression_NN
in_FW
vivo_FW
of_IN
Fos_NN
,_,
and_CC
to_TO
a_DT
lesser_JJR
extent_NN
Fra-1_NN
,_,
eliminates_VBZ
the_DT
requirement_NN
for_IN
phorbol_NN
12-myristate_NN
13-acetate_NN
-LRB-_-LRB-
PMA_NN
-RRB-_-RRB-
stimulation_NN
,_,
leaving_VBG
NF-AT-directed_JJ
transcription_NN
responsive_JJ
to_TO
calcium_NN
ionophore_NN
alone_RB
._.

Overexpression_NN
of_IN
cJun_NN
or_CC
JunD_NN
,_,
but_CC
not_RB
JunB_NN
,_,
also_RB
eliminates_VBZ
the_DT
requirement_NN
for_IN
PMA_NN
,_,
indicating_VBG
that_IN
many_JJ
but_CC
not_RB
all_DT
Jun_NN
-_:
and_CC
Fos-related_JJ
proteins_NNS
functionally_RB
activate_VBP
NF-AT-dependent_JJ
transcription_NN
in_IN
the_DT
presence_NN
of_IN
the_DT
cytoplasmic_JJ
component_NN
._.

NF-AT_NN
DNA_NN
binding_NN
can_MD
be_VB
reconstituted_VBN
in_FW
vitro_FW
using_VBG
semi-purified_JJ
AP1_NN
proteins_NNS
mixed_VBN
with_IN
cytosol_NN
from_IN
T_NN
lymphocytes_NNS
._.

Fos_NN
proteins_NNS
are_VBP
not_RB
needed_VBN
for_IN
this_DT
reconstitution_NN
,_,
and_CC
although_IN
JunB_NN
is_VBZ
not_RB
functional_JJ
,_,
it_PRP
can_MD
participate_VB
in_IN
the_DT
NF-AT_NN
DNA_NN
binding_NN
complex_NN
._.

Finally_RB
,_,
we_PRP
have_VBP
partially_RB
purified_VBN
the_DT
cytoplasmic_JJ
component_NN
of_IN
NF-AT_NN
and_CC
show_VBP
by_IN
elution_NN
and_CC
renaturation_NN
from_IN
SDS-polyacrylamide_JJ
gel_NN
electrophoresis_NN
gels_NNS
that_IN
it_PRP
has_VBZ
a_DT
molecular_JJ
mass_NN
between_IN
94_CD
and_CC
116_CD
kDa_NN
and_CC
may_MD
have_VB
multiple_JJ
differentially_RB
modified_JJ
forms_NNS
._.

